Roger Briesewitz
The Ohio State University(US)
Publications by Year
Research Areas
Cell Adhesion Molecules Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, PI3K/AKT/mTOR signaling in cancer, Monoclonal and Polyclonal Antibodies Research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin(2008)496 cited
- → Sp1/NFκB/HDAC/miR-29b Regulatory Network in KIT-Driven Myeloid Leukemia(2010)244 cited
- → Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome(2003)202 cited
- → Efficient Delivery of Cyclic Peptides into Mammalian Cells with Short Sequence Motifs(2012)184 cited
- → Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia(2007)157 cited
- → Inhibition of Ras Signaling by Blocking Ras–Effector Interactions with Cyclic Peptides(2015)146 cited
- → Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia(2007)133 cited
- → The role of the I domain in ligand binding of the human integrin alpha 1 beta 1.(1994)124 cited
- → Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies(2013)109 cited
- → Expression of native and truncated forms of the human integrin alpha 1 subunit.(1993)109 cited